Pappalardo A, Sallì L, Campisi D, Scalici G, Di Marco C, Martorana U
Clin Ter. 1989 Mar 15;128(5):321-7.
Fifteen subjects with rheumatoid arthritis defined as "classical" or "definite" according to A.R.A. criteria and classified according to Steinbrocker as stages I to III were submitted to knee joint infiltration (bilateral where both knees were involved) with 50 mg thymopentin in 1 ml, once a week for five weeks. Telethermographic examination was performed in all cases in order to evaluate the thermal inflammatory component before the first and 48 hours after the last infiltration. In none of the patients with the exception of only one case, did the drug lead to a significant change of the thermal index. This evaluation does not take into account any other objective and subjective parameters the study of which was beyond the scope of the above research.
15名根据美国风湿病协会（A.R.A.）标准被定义为“典型”或“确诊”类风湿性关节炎且按照斯坦布鲁克（Steinbrocker）分类为I至III期的受试者，接受了膝关节注射（双膝受累则双侧注射），注射药物为1毫升含50毫克胸腺五肽，每周一次，共五周。所有病例均进行了远红外热像图检查，以评估首次注射前及最后一次注射后48小时的热炎症成分。除仅1例患者外，该药物未导致任何患者的热指数发生显著变化。本评估未考虑任何其他客观和主观参数，对这些参数的研究超出了上述研究范围。
